Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry tech./dosim.

By: Russo RJ
Published in: Am Heart J 2013; 165 (3): 266-272
Download citation in RIS format

Exposure